Brief: Biomed Lublin Resolves To Modify Process Of Financing Acquisition
May 4 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA BML.WA :
* RESOLVES TO MODIFY PROCESS OF ACQUIRING FINANCING
* RESOLVES TO ISSUE 1.7 MILLION OF NEW SHARES AT 12.33
ZLOTYS PER
SHARE WHICH WILL OFFER TO IPOPEMA
* ITS INTENTION IS CONTINUATION TOGETHER WITH IPOPEMA OF
ACQUIRING
CAPITAL REGARDING REMAINING 1.3 MILLION BORROWED SHARES
Source text for Eikon: ID:nEM3vvndHa
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility